Dextromethorphan Hydrobromide is a centrally acting non-narcotic antitussive that acts on sigma-1 receptors and NMDA receptors, the most widely used OTC cough suppressant globally and also a component of emerging neurological combination therapies. Simson Pharma's Dextromethorphan Hydrobromide reference standard and impurities support high-volume compendial testing for this OTC respiratory mainstay.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Dextromethorphan Hydrobromide Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.